Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mast cells: new targets for multiple sclerosis therapy?

Jacques P Zappulla1, Michel Arock, Lennart T Mars

  • 1INSERM U546, Pitié Salpêtrière Hospital, 105 Boulevard de l'Hôpital, 75634 Cedex 13, Paris, France.

Journal of Neuroimmunology
|November 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same author

Narcolepsy is (not) an autoimmune disease.

Nature reviews. Neurology·2026
Same author

CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

Leukemia·2026
Same author

Soluble FcεRI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation.

The Journal of allergy and clinical immunology·2026
Same author

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation.

Current allergy and asthma reports·2026
Same author

MASTering KIT: enhanced sensitivity for refined diagnosis.

Blood·2025

Mast cells are increasingly recognized for their role in multiple sclerosis (MS) inflammation and demyelination. Targeting these cells could offer new therapeutic strategies for MS.

Area of Science:

  • Neuroimmunology
  • Cellular Biology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system.
  • Mast cells (MCs) are immune cells implicated in various inflammatory conditions.

Purpose of the Study:

  • To explore the role of mast cells in the pathophysiology of multiple sclerosis.
  • To evaluate the potential of mast cells as therapeutic targets in MS.

Main Methods:

  • Review of current literature and animal model studies on mast cells in MS.
  • Analysis of mast cell involvement in inflammatory and demyelinating processes.

Main Results:

  • Mast cells influence multiple aspects of multiple sclerosis, including disease induction and severity.

Related Experiment Videos

  • Evidence from animal models suggests a significant role for mast cells in MS pathogenesis.

    • Conclusions:

    • Mast cells are critical players in multiple sclerosis, impacting disease progression.
    • Modulating mast cell activity presents a promising avenue for novel MS therapies.